Printer-friendly versionPrinter-friendly version

Prevention and control of viral hepatitis in Brazil and other Latin American Countries, lessons learnt and the way forward.

March 19-21, 2014- Brasilia, Brasil

Objectives of the meeting:

  • Introduce the Viral Hepatitis Prevention Board (VHPB), an organisation focussing for more than 22 years on the prevention and control of viral hepatitis: way of working, achievements and impact;
  • Hepatitis in Latin America:
    • Review the epidemiological situation on viral hepatitis in Latin America;
    • Discuss the progress achieved in hepatitis prevention in Latin American countries;
    • Discuss specific hepatitis issues in Latin America that need attention in the future;
  • Brazil: Review viral hepatitis in Brazil:
    • Give an overview of the current prevention and control measures on viral hepatitis and other hepatitis issues in Brazil;
    • Review the possible implementation of new prevention strategies, control measures and monitoring systems;
    • Discuss the successes, issues and barriers to overcome, and the way forward;
  • Discuss the possible input and impact of Viral Hepatitis Prevention Board to consolidate cooperation programmes to face viral hepatitis issues in Brazil and other Latin American countries.

Pre-meeting document 436KB (.pdf)

WEDNESDAY, March 19, 2014

18.00 - 19.00 Registration

19.00 - 20.30

SESSION 1:  Opening and objectives
Chair: 

  • Arthuf Chioro (Brazilian Minister of health)
  • Jarbas Barbosa (SVS/MOH)
  • Joaquin Molina (PAHO representative Brazil)
  • Massimo Ghidinelli (Head of STD/AIDS, Hepatitis and Turberculosis of PAHO/ WHO Washington)
  • Fábio Mesquita (MOH)
  • Raymundo Paranà (SBH)
  • Pierre Van Damme (VHPB)

     

    • Welcome and opening
    • Introduction of the participants
    • Objectives of the meeting

19.40 – 20.00
Viral hepatitis in Latin America and the Caribbean: a public health challenge - 1.6Mb(.pdf)
Massimo Ghidinelli , (PAHO)

20.00 – 20.20
The 2014 Brazilian Resolution at the World Health Assembly - 322KB(.pdf)
Fábio Mesquita , (BRA-MOH)

20.20 – 20.30 Q&A

20.20 Welcomes reception

 

Thursday, March 20, 2014

PART I    VIRAL HEPATITIS PREVENTION BOARD - VHPB

SESSION 2:  Viral hepatitis prevention board - VHPB
Chair: Wolfgang Jilg(VHPB-Germany) and Joana Carvalho Costa (Technical advisor to the Department of sTD, AIDS and Viral hepatitis - Brazil)

09.00 – 09.20
Introduction of the VHPB - 2MB(.pdf)
Pierre Van Damme (VHPB, VAXINFECTIO - Antwerp, Belgium)

09.20 – 09.50
22 years VHPB: realisations and impact - 2MB(.pdf)
Mark Kane (VHPB Honorary member – USA) and Johannes Hallauer (VHPB – Germany)

Impact of VHPB meeting in a country

09.50 – 10.05
Portugal - 5MB(.pdf)
Rui Tato Marinho 

10.05 – 10.20
Bulgaria  - 615KB(.pdf)
Mira Kojouharova

10.45 – 11.05
Israel - 1MB(.pdf)
Daniel Shouval

10.35 – 10.45 Q&A

10.45 – 11.05 Coffee Break

SESSION 3:  World Viral Hepatitis
Chair: Tatjana Reic (VHPB-ELPA) and Evaldo Stanislau (Medicine School of University of Sao Paulo-Brasil)

WHO Global Viral Hepatitis plan- 1.9 MB(.pdf)
Massimo Ghidinelli  (Head of STD/AIDS, Hepatitis and Tuberculosis of the Pan American Health Organisation PAHO/ WHO)

09.50 – 10.10
World HepatitisAlliance – Patient point of view - 231KB (.pdf)
Charles Gore  (World Hepatitis Alliance - WHA)

10.30 – 10.45 Q&A

10.45 – 11.05 Lunch

 

PART II    OVERVIEW OF VIRAL HEPATITIS IN LATIN AMERICA

SESSION 4:  Viral hepatitis Situation in Latin America
Chair: Rui Tato Marinho (VHPB-Portugal), Maria Cassia Mendes Correa  (Medicine school of University of Sao Paolo-Brazil)

13.30 – 13.50
The Brazilian mathematical model  - 1.4MB (.pdf)
Marcelo Nascimento Burattini  (Medicine school of University of Sao Paolo-Brazil)

13.50 – 14.10
Treatment Guidelines of the Latin American Association for the Study of the Liver. -2.4MB (.pdf)
Nahum Méndez-Sánchez   (Medical Sur. Clinic&Foundation-Mexico)

14.10 – 14.30
The burden of hepatocellular carcinoma related to viral hepatitis in LA. - 3.5MB (.pdf)
Raymundo Paraná   (Representative of the Brazilian Society of Hepatology)

14.30 – 14.50
Liver transplantation in Latin America. 3.2MB (.pdf)
Paulo Celso Bosco Massarollo  (Santa Casa de Misericordia from Sao Paulo-Brazil)

14.50 – 15.10 Q&A

15.10 – 15.45 Coffee Break

SESSION 5:  Viral hepatitis issues in the different latin American Countries
Chair: Daniel Lavanchy (VHPB Honorary-Switzerland) and  Marcelo Contardo Moscoso Naveira (Johns Hopkins, USA-Brazil)

15.45 – 16.05
Argentina - 3.3kB (.pdf)
Gabriela Vidiella  (Argentine Ministry of Health)

16.05 – 16.25
Carribean - 748kB (.pdf)
Fernando A. Contreras Pena  (Center for Adanced Gastroenterology- Chile)

16.25 – 16.45
Peru. - 3.9Mb (.pdf)
Carlos Manuel Benites Villafane  (Peruvian Ministry of Health)

16.45 – 17.05 Discussion

SESSION 6:  Face viral hepatitis control in Latin America
Chair: Daniel Shouval (VHPB-Israel), Themis Rebervel Silveira (Hospital SAnto Antonio-RS, Brazil)

17.05 – 17.25
Impact of the single-dose immunization strategy against hepatitis A in Argentina. -  4.1MB(.pdf)
Jorge Enrique  Gonzalez ( National institute of infectious diseases - Argentina)

17.25– 17.40
Hepatitis E infection in Latin America - 3MB (.pdf)
Angelo Alves de Mattos (Latin American Association of the Study of the Liver)

17.40 – 18.00
Difficulty to implement an integrated Molecular Biology tool in Latin America. - 1.1MB (.pdf)
Andreas Stöcker (University Hospital Edgard Santos-Brazil)

18.00 – 18.20
The building of a viral hepatitis network in Latin America. - 1.7MB(.pdf)
Marcelo Silva   (University Hospital Austral-Argentina)

18.20 – 18.40 Discussion

20.00       Meeting Dinner

 

Friday, March 21, 2014

PART III    PREVENTION AND CONTROL OF VIRAL HEPATITIS IN BRAZIL

SESSION 7:  Health Care system in Brazil
Chair: Mark Kane (VHPB Honorary-USA) and Denise Rinehart (CONASEMS-Brazil)

09.00 – 09.20
Organization of the public health system in Brazil. - 808KB(.pdf)
André Luis Bonifácio de Carvalho (Secretariat of Strategic and Participative Management, Ministry of Health, Brazil)

09:15 – 09:30
Burden of liver disease in Brazil . - 3.3MB(.pdf)
Angelo Alves de Mattos (Latin American Association of the Study of the Liver)

09.30 – 09.45
The Brazilian response to viral hepatitis /Brazilian Hepatitis Plan . - 258kB (.pdf)
Marcelo Contardo Moscoso Naveira (Johns Hopkins, USA-Brazil)

09.45 – 10.00
Brazilian vaccination program, coverage rates and vaccine manufacturing. 
Paulo Lee Ho (Butantan Institute, Sao PAulo, Brazil)

10.00 – 10.15 Discussion

SESSION 8:  Epidemiology and burden of viral hepatitis in Brazil
Chair: Angela Dominguez (VHPB-Spain) and Angelo Alves de Mattos (Latin American Association of the Study of the Liver)

10.15 – 10.30
Hepatitis A and E  - 2.3MB (.pdf)
Themis Rebervel Silveira  (Hospital Santo Antonio-RS, Brazil)

10.30 – 10.45
Epidemiological heterogeneity of infections with hepatitis B and D viruses in Brazil - 1.2MB(.pdf)
Gilberta Bensabath (Evandro Chagas Institure of Para, Brazil)

10.45 – 11.00
Hepatitis C  - 2.4MB (.pdf)
Evaldo Stansilau  (Medicine School of University of Sao Paulo-Brazil)

11.00 – 11.15 Discussion

11.15 – 11.30 Coffee Break

SESSION 9:  Hepatitis in special risk groups/regions in Brazil
Chair: Heléne Norder (VHPB-Sweden) and Thor Oliveira Dantas (SAE/SESACRE-Brazil)

11.30 – 11.45
HIV and HBV/HCV co-infection  - 432KB (.pdf)
João Silva de Mendonça  (Department of infecious diseases HSPE- Brazil)

11.45 – 12.00
Particular matters of viral hepatitis in the Brazilian Amazon -3.5 MB (.pdf)
Juan Miguel Villalobos Salcedo  (Fiocruz-RO, Brazil).

12.00 – 12.15
Molecular epidemiology of hepatitis C, B and D infection in Brazilian Amazonia  - 2.8MB (.pdf)
Wornei Braga  (Tropical Medicine Foundaton of Amazonas).

12.15 – 12.30 Discussion

12.30 – 14.15 Lunch

SESSION 10:  Future Challenges
Chair: Pierre Van Damme (VHPB-Belgium) and Raymundo Paraná (Representative of the Brazilian Society of Hepatology)

14.15 – 14.30
Challenges for viral hepatitis prevention in Latin America - 875KB (.pdf)
Laura Alves De Souza  (Technical Advisor of the Department of STD/AIDS and viral hepatitis-Brazil).

14.30 – 14:45
Challenges to care viral hepatitis patients in Latin America.- 1.4MB (.pdf)
Edison Parise  (President of the Brazilian Society of Hepatology).

14.45 – 15.00
The role of civil society to define national response to viral hepatitis -1.9MB (.pdf)
Carlos Norberto Varaldo  (Optimism Support Groups Hepatitis Carriers-Brazil).

15.00 – 15.15
Logistic problems to face delta hepatitis in the Amazonian countries - 1.4MB (.pdf)
Thor Oliveira Dantas  (SAE/SESACRE-Brazil).

15.15 – 15.30
Cost of viral hepatitis treatment and challenges -966KB (.pdf)
Fábio Mesquita  (Director of the Department of STD/AIDS and viral hepatitis-Brazil).

15.30 – 16.00 Q&A - meeting Discussion

16.00 – 16.30 Coffee Break

SESSION 11:  Conclusions of the meeting
Chair: : Johannes Hallauer (VHPB-Germany) and Fábio Mesquita (Director of the Department of STD/AIDS and viral hepatitis-Brazil)

16.30 – 17.30
Presentation of the meeting conclusions - 58KB (.pdf)
David FitzSimons  (Rapporteur).

Tags: